iCAD, Inc. (ICAD)
3.870
+0.140 (3.75%)
Inactive · Last trade price on Jul 16, 2025
ShockWave Medical Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for ShockWave Medical.
Price Target: $ (0.00%)
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for ShockWave Medical is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Laidlaw & Co. | Laidlaw & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 17, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $2.5 → $5 | Strong Buy | Maintains | $2.5 → $5 | +29.20% | Jul 19, 2023 |
| JMP Securities | JMP Securities | Buy Maintains $7 → $4 | Buy | Maintains | $7 → $4 | +3.36% | Apr 13, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $5 → $4 | Buy | Maintains | $5 → $4 | +3.36% | Apr 4, 2023 |
| BTIG | BTIG | Strong Buy Maintains $4 → $3 | Strong Buy | Maintains | $4 → $3 | -22.48% | Mar 29, 2023 |
Financial Forecast
Revenue This Year
20.31M
from 19.61M
Increased by 3.60%
Revenue Next Year
18.50M
from 20.31M
Decreased by -8.95%
EPS This Year
-0.18
from -0.21
EPS Next Year
-0.12
from -0.18
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 21.6M | 23.9M | 32.2M |
| Avg | 20.3M | 18.5M | 23.4M |
| Low | 18.8M | 13.2M | 15.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 10.2% | 17.7% | 73.9% |
| Avg | 3.6% | -8.9% | 26.6% |
| Low | -4.2% | -34.9% | -18.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.17 | -0.09 | 0.11 |
| Avg | -0.18 | -0.12 | - |
| Low | -0.20 | -0.14 | -0.10 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.